Skip to main content
OpenTrials

Clinical trial condition

Early Stage HER2+ Breast Cancer

Explore clinical trials studying Early Stage HER2+ Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Early Stage HER2+ Breast Cancer trial results

Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

NCT06876714

Conditions
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Early Stage HER2+ Breast Cancer
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
View all 671 locations
View Trial Details
Completed

An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide

NCT02400476

Conditions
Breast Diseases, Breast Neoplasms, Early Stage HER2+ Breast Cancer, +4 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Compassionate Care Research Group Inc. Corona, California, United States
  • St. Joseph Heritage Healthcare Fullerton, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
View all 58 locations
View Trial Details

Related conditions